Addex Therapeutics (NASDAQ:ADXN) reported quarterly losses of $(1.37) per share. This is a 73.69 percent increase over losses of $(5.20) per share from the same period last year. The company reported $268.83 thousand in sales this quarter. This is a 50.44 percent decrease over sales of $542.43 thousand the same period last year.
Addex Therapeutics Q1 EPS $(1.37) Up From $(5.20) YoY, Sales $268.83K Down From $542.43K YoY
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.